Lactobacillus Reuteri Strain Combination in Children Treated With PPI
Recruiting
N/A
Interventional Study
Gastric Lesion
Proton Pump Inhibitor Adverse Reaction
Probiotic
At a Glance
- Age
- 12 Months – 14
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 172 (estimated)
- Sponsor
- University of Bari · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Probiotics might be of help in preventing dysbiosis and emergence of SIBO. Gastrus consisted of a mixture of two human strains of L. Reuteri DSM 17938 and ATCC PTA 6475; the first have extensive data supporting its use in gastric infections (18) however, it lacks the anti-inflammatory properties that have been provided by L. Reuteri DSM ATCC PTA 6475 that has excellent acid resistance and has stro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age: children between 1 month and 14 years of age;
o We start with children older than 4 years of age.
* Necessity of therapy with Proton Pump Inhibitors for Gastroesophageal reflux disease and/or Functional Dyspepsia;
* Informed consent obtained.
Exclusion Criteria:
* Ne…
Contacts